Deoxyribonuclease II is a lysosomal barrier to transfection
Open Access
- 1 December 2003
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 8 (6), 957-963
- https://doi.org/10.1016/j.ymthe.2003.09.011
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Phage display selection of a peptide DNase II inhibitor that enhances gene deliveryThe Journal of Gene Medicine, 2001
- Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transferGene Therapy, 1999
- Enhanced reporter gene expression in cells transfected in the presence of DMI-2, an acid nuclease inhibitorGene Therapy, 1998
- Porcine Spleen Deoxyribonuclease IIPublished by Elsevier BV ,1998
- On the mechanism of DNA transfection: efficient gene transfer without virusesGene Therapy, 1997
- Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.JCI Insight, 1997
- DMI-2 AND DMI-3, DNA METHYLTRANSFERASE INHIBITORS PRODUCED BY STREPTOMYCES SP. STRAIN NO. 560Journal of Enzyme Inhibition, 1996
- Overexpression of Uteroferrin, a Lysosomal Acid Phosphatase Found in Porcine Uterine Secretions, Results in its High Rate of Secretion from Transfected Fibroblasts1Biology of Reproduction, 1993
- Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion.The Journal of cell biology, 1992
- Choloroquine inhibition of repair of DNA damage induced in mammalian cells by methyl methanesulfonateMutation Research, 1974